AstraZeneca PLC (AZN)
204.80
+4.33
(+2.16%)
USD |
NYSE |
Apr 17, 16:00
201.70
-3.10
(-1.51%)
Pre-Market: 08:30
AstraZeneca SG&A Expense (Quarterly) : 152.78M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| GSK Plc | 3.510B |
| Mereo BioPharma Group Plc | 4.191M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| BioNTech SE | 253.62M |
| Moderna, Inc. | 308.00M |